Page last updated: 2024-08-17

bromodeoxyuridine and osu 03012

bromodeoxyuridine has been researched along with osu 03012 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CS; D'Ambrosio, SM; Ding, H; Duan, W; Guo, D; Han, C; Wang, D1

Other Studies

1 other study(ies) available for bromodeoxyuridine and osu 03012

ArticleYear
Sensitivity to the non-COX inhibiting celecoxib derivative, OSU03012, is p21(WAF1/CIP1) dependent.
    International journal of cancer, 2008, Dec-15, Volume: 123, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Bromodeoxyuridine; Cell Line; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Embryo, Mammalian; Fibroblasts; Flow Cytometry; G1 Phase; Gene Silencing; Humans; Immunoprecipitation; Mice; Mouth Mucosa; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Papillomavirus Infections; Proto-Oncogene Proteins; Pyrazoles; Repressor Proteins; Sulfonamides; Tumor Virus Infections

2008